112 related articles for article (PubMed ID: 10370642)
21. Effect of somatostatin on lower esophageal sphincter characteristics in man.
Straathof JW; Tieleman S; Lamers CB; Masclee AA
Scand J Gastroenterol; 2000 Sep; 35(9):910-5. PubMed ID: 11063148
[TBL] [Abstract][Full Text] [Related]
22. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression.
Selley ML
J Affect Disord; 2004 Jun; 80(2-3):249-56. PubMed ID: 15207938
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of linsidomine chlorhydrate, a direct nitric oxide donor, in the treatment of human erectile dysfunction: results of a double-blind cross over trial.
Wegner HE; Knispel HH; Klän R; Miller K
Int J Impot Res; 1995 Dec; 7(4):233-7. PubMed ID: 8770666
[TBL] [Abstract][Full Text] [Related]
24. Intraoperative manometry of the lower esophageal sphincter pressure during laparoscopic antireflux surgery with a mechanical calibration--early results.
Kala Z; Dolina J; Kysela P; Hermanová M; Procházka V; Kroupa R; Izakovicová-Hollá L; Hep A
Hepatogastroenterology; 2006; 53(71):710-4. PubMed ID: 17086874
[TBL] [Abstract][Full Text] [Related]
25. Physiological studies on nitric oxide in the lower esophageal sphincter of patients with reflux esophagitis.
Tomita R; Tanjoh K; Fujisaki S; Fukuzawa M
Hepatogastroenterology; 2003; 50(49):110-4. PubMed ID: 12630004
[TBL] [Abstract][Full Text] [Related]
26. Effect of electrical stimulation of the LES on LES pressure in a canine model.
Sanmiguel CP; Hagiike M; Mintchev MP; Cruz RD; Phillips EH; Cunneen SA; Conklin JL; Soffer EE
Am J Physiol Gastrointest Liver Physiol; 2008 Aug; 295(2):G389-94. PubMed ID: 18687754
[TBL] [Abstract][Full Text] [Related]
27. Effect of intraduodenal peptone on the lower esophageal sphincter pressure in the dog.
Koelz HR; Lepsien G; Hollinger AP; Säuberli H; Largiadèr F; Arnold R; Blum AL; Siewert R
Gastroenterology; 1978 Aug; 75(2):283-5. PubMed ID: 669214
[TBL] [Abstract][Full Text] [Related]
28. Interaction of somatostatin and pentagastrin on lower oesophageal sphincter pressure (LESP) in man.
Rösch W; Lux G; Schittenhelm W; Demling L
Acta Hepatogastroenterol (Stuttg); 1976 Jun; 23(3):209-12. PubMed ID: 941623
[TBL] [Abstract][Full Text] [Related]
29. The effect of theophylline on the lower esophageal sphincter pressure.
Stein MR; Towner TG; Weber RW; Mansfield LE; Jacobson KW; McDonnell JT; Nelson HS
Ann Allergy; 1980 Oct; 45(4):238-41. PubMed ID: 7425397
[TBL] [Abstract][Full Text] [Related]
30. Does an acute increase of intraabdominal pressure effect esophageal sphincter pressure?
Yilmaz N; Musoglu A; Oner S; Bor S
Hepatogastroenterology; 2007 Mar; 54(74):434-7. PubMed ID: 17523291
[TBL] [Abstract][Full Text] [Related]
31. A rapid pull-through technique for measuring lower esophageal sphincter pressure.
Dodds WJ; Hogan WJ; Stef JJ; Miller WN; Lydon SB; Arndorfer RC
Gastroenterology; 1975 Mar; 68(3):437-43. PubMed ID: 1089576
[TBL] [Abstract][Full Text] [Related]
32. Effects of long-term oral L-arginine on esophageal motility and gallbladder dynamics in healthy humans.
Luiking YC; Weusten BL; Portincasa P; Van Der Meer R; Smout AJ; Akkermans LM
Am J Physiol; 1998 Jun; 274(6):G984-91. PubMed ID: 9696721
[TBL] [Abstract][Full Text] [Related]
33. [Barrier function of esophagogastric junction in patients with gastroesophageal reflux disease].
Ding ZL; Wang ZF; Li HB; Sun XH; Xu L; Ke MY
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(34):2382-5. PubMed ID: 17156646
[TBL] [Abstract][Full Text] [Related]
34. Expression of inducible nitric oxide synthase in the lower esophageal sphincter of the endotoxemic opossum.
Park H; Clark E; Cullen JJ; Koland JG; Kim MS; Conklin JL
J Gastroenterol; 2002; 37(12):1000-4. PubMed ID: 12522530
[TBL] [Abstract][Full Text] [Related]
35. Stimulation of lower esophageal sphincter pressure (LESP) by cimetidine -- a double-blind study.
Roesch W; Lux G; Schittenhelm W; Demling L
Acta Hepatogastroenterol (Stuttg); 1976; 23(6):423-5. PubMed ID: 1007830
[TBL] [Abstract][Full Text] [Related]
36. Molecular aspects underlying the vasodilator action of molsidomine.
Noack E; Feelisch M
J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S1-5. PubMed ID: 2484685
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of molsidomine and of its active metabolite, SIN-1 (or linsidomine), in the elderly.
Spreux-Varoquaux O; Ulmer B; Cordonnier P; Forestier A; Pays M; Ducreuzet C; Advenier C
Fundam Clin Pharmacol; 1991; 5(6):549-56. PubMed ID: 1955198
[TBL] [Abstract][Full Text] [Related]
38. [Molsidomine in chronic heart failure with liver congestion--oral or intravenous therapy?].
Grosse-Heitmeyer W; Huber T; Ostrowski J
Med Klin (Munich); 1993 Jan; 88(1):21-5. PubMed ID: 8437528
[TBL] [Abstract][Full Text] [Related]
39. [Effect of Pitressin (8-arginine vasopressin) on the lower esophageal sphincter in dogs].
Watanabe M; Sugawa C; Hatafuku T; Mori S
Nihon Geka Gakkai Zasshi; 1984 Mar; 85(3):231-7. PubMed ID: 6472251
[TBL] [Abstract][Full Text] [Related]
40. Different effects of white and red wine on lower esophageal sphincter pressure and gastroesophageal reflux.
Pehl C; Pfeiffer A; Wendl B; Kaess H
Scand J Gastroenterol; 1998 Feb; 33(2):118-22. PubMed ID: 9517519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]